Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subjective Effects of PTI-801 in Subjects with History of Drug Abuse
NCT00734461Phase 2Completed
- Sponsor
- Cassava Sciences
- Start
- Aug 2007
- Primary completion
- Mar 2009
- Modality
- Drug Delivery Systems, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxycodone + naltrexone in pain (7 arms), sponsored by Cassava Sciences. Primary endpoints: Visual Analog Scale Liking, Visual Analog Scale High and 5 more. Started Aug 2007; status: completed.
02
Drugs
oxycodone + naltrexone
03
Conditions
pain
Beyond the preview
Go deeper on NCT00734461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734461.